CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial

Nirali N. Shah, Terry J. Fry, Haneen Shalabi et al.|Journal of Clinical Oncology|2020

Cited by 422